14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Tue, 7 May 2024

Trading levels for CTSO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.99 12.05 %
R2 0.94 6.88 %
R1 0.91 3.69 %
Current price: 0.88
Support S1 0.82 -6.64 %
S2 0.793 -9.83 %
S3 0.748 -15.00 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.02 15.91 %
R2 1.01 14.77 %
R1 0.96 8.52 %
Current price 0.88
Support S1 0.82 -6.63%
S2 0.82 -6.89%
S3 0.81 -7.95%

CTSO Predictions History

1 year ago
Km16m predicted that CTSO for 2023-02-07 is going

Rank:

1 year ago
JS predicted that CTSO for 2023-02-06 is going $3.37 (-19.18%)

1 year ago
PredictionBot.Kathy predicted that CTSO for 2023-02-06 is going $3.46 (-16.95%)

1 year ago
PredictionBot.Warren predicted that CTSO for 2023-02-06 is going $3.50 (-16.08%)

3 years ago
JS predicted that CTSO for 2021-02-01 is going $10.12 (-5.68%)

3 years ago
Noah Ford predicted that CTSO for 2021-02-01 is going

Rank:

3 years ago
JS predicted that CTSO for 2020-05-14 is going $10.74 (3.77%)

3 years ago
Zhiqiao Huang predicted that CTSO for 2020-05-14 is going

Rank:

3 years ago
Jeff Prakash predicted that CTSO for 2020-05-14 is going $12.50 (18.09%)

Rank:

3 years ago
JS predicted that CTSO for 2020-05-11 is going $10.64 (0.85%)

Click to get the best stock tips daily for free!

About Cytosorbents Corporation

Cytosorbents Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention and treatment of perioperative complication... CTSO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT